Lung cancer pill shows 'earth-shattering' results
-
I assume this is the work of Doctor Jill and the cancer moonshot.
Lung cancer pill shows 'earth-shattering' results in 5-year study: 'An optimistic time'
Hackensack Meridian's Dr. Faiz Bhora shares his experience with Tagrisso in 'the era of personalized medicine'
Many lung cancer patients now have access to a potentially life-saving medication.
Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a certain genetic mutation and have had surgery to remove cancerous tumors.
Among those patients, Tagrisso was shown to reduce the five-year risk of recurrent cancer by up to 73% and the risk of death by up to 51%, according to research published in The New England Journal of Medicine over the summer.
